Nancy C. G. Snowden

Nancy C. G. Snowden is the CEO and Founder of NCGS. Ms. Snowden’s background is in oncology, transplant medicine and critical care. Ms. Snowden has more than 30 years in the life sciences industry. Prior to establishing NCGS, Ms. Snowden functioned as the research lead of an NIH/NCI funded grant at the Medical College of Georgia/University Hospital, establishing one of the first Community Clinical Oncology Programs (CCOP) and producing one of the top enrolling initial centers. NCGS is a full-service CRO founded in 1984 focusing on oncology, CNS, ID and Critical Care indications. NCGS has contributed to the approval of 31 products with ZERO 483s.